Background: Evidence-based clinical practice guidelines (CPGs) are defined as "statements that are scientifically reviewed about evidence and systematically developed to assist in the doctors' and patients' decision making in certain clinical situations." This recommendation aims to promote good clinical practice for the provision of safe and effective practices of conscious sedation in dentistry. Method: The development of this clinical practice guideline was conducted by performing a systematic search of the literature for evidence-based CPGs. Existing guidelines, relevant systematic reviews, policy documents, legislation, or other recommendations were reviewed and appraised. To supplement this information, key questions were formulated by the Guideline Development Group and used as the basis for designing systematic literature search strategies to identify literature that may address these questions. Guideline documents were evaluated through a review of domestic and international databases for the development of a renewing of existing conscious sedation guidelines for dentistry. Clinical practice guidelines were critically appraised for their methodologies using Appraisal of guidelines for research and evaluation (AGREE) II. Results: A total of 12 existing CPGs were included and 13 recommendations were made in a range of general, adult, and pediatric areas. Conclusion: The clinical practice guidelines for conscious sedation will be reviewed in 5 years' time for further updates to reflect significant changes in the field.
INTRODUCTION
In 1990, the Institute of Medicine (IOM) defined clinical practice guidelines that were "systematically developed to assist in the doctors' and patients' decision making in a particular situation" [1] . In 2011, evidence based medicine has since revised this definition to the following: "statements that are the assessment of their benefits and harms other treatment methods and the basis of the system through literature review including recommendations to optimize patient care" [2] . The definition in Korea was agreed upon via mutual consensus by a panel of experts based upon the modified Delphi method, to the following: "statements that are scientifically reviewed about evidence and systematically developed to assist in the doctors' and patients' decision making in certain clinical situations" [3] . With the prevalence of dental implantation in the field of dentistry, the need for behavioral control in pediatric patients and patients with special health care needs is increasing. Additionally, dental sedation has also been receiving particular attention. As dental sedation becomes more widely used in dental clinics, its benefits, such as the management of anxiety and pain, have also been noted. However, concurrent reports of adverse effects and the incidence of severe complications related to dental sedation have also increased. Therefore, the dental sedation clinical practice guidelines necessitated review, and a 5-year follow-up to the publication of the original guidelines was performed.
The Korean Dental Society of Anesthesiology proposed a revision in 2014, and consequently, the "Dental Sedation Clinical Practice 2015" was an additional revised document of the original published by researchers under the recommendations of the academy of dental sedation at the Korean Academy of Dental Sciences. The American Dental Association defines evidence-based dentistry as "an approach to oral healthcare that requires the judicious integration of systematic assessments of clinically relevant scientific evidence, relating to the patient's oral and medical condition and history, with the dentist's clinical expertise and the patient's treatment needs and preferences" [4] . An evidence-based approach was developed to supplement the absence of explicit standards and methodologies within the former method.
This new approach was developed along with an advancement of evidence-based medical methods [5] .
This involved the introduction of bibliographic search software that allowed for a systematic examination of the literature and the minimization of errors in the evidence selection process. Moreover, the increase in metaanalyses performed and the creation of influential data sources, such as the Cochrane database, has recently facilitated evidence stratification. Consequently, recommendations were formulated after more convincing processes were made apparent. At present, an evidence-based development method is advantageous and more commonly employed because of its objective, evaluative, and deductive recommendations [6] [7] [8] . However, from the user's perspective, the question of 'how the guideline has been developed' persists. In addition, compared to earlier stages of guideline development, the more recent modifications of the guidelines could be considered confusing. Therefore, to validate the reliability of the guidelines, the Committee of Clinical Practice Guideline reviews the current progress in the development of clinical guidelines.
MATERIALS AND METHODS
The 2015 REVISED dental sedation clinical practice guidelines, or Guidance for the development of clinical practice guidelines Ver 1.0 [9] , were developed using the Appraisal of guidelines for research and evaluation (AGREE) II framework for a Korean context (Table 1) .
A review panel of experts from the Committee of Clinical
Practice Guideline (CPG) of the Korean Academy of Medical Sciences (KAMS) reviewed the literature and revised the existing clinical guidelines. These revised guidelines reflect the reality of dental sedation more accurately than the previous version published in 2010 [10] , and were based on evidence obtained from clinically useful questions (PICOH) ( Table 2) .
A hybrid method that combined the novel and adaptive development approaches was used for the development of the guidelines (Fig. 1) .
The term used in clinical practice guidelines is based on the fifth edition of the medical glossary of terms published by the Korean Medical Association. The development of these clinical practice guidelines involved a systematic search of the literature based on the availa- The AGREE II framework, which is an appraisal tool, was used to evaluate and critically appraise the CPGs.
The title and abstract of each reference was screened for relevance independently by two researchers who were not members of the Guidance Development Group. Disagreements about the inclusion of specific individual references requiring further consideration were resolved by discussion, and if necessary, the opinion of a third researcher was sought. For the inclusion of CPGs, original reports published in English and Korean that described the intervention strategies in sufficient detail were included.
A second requirement was that the CPGs needed to be There are guidelines for applying the instruments 1 2 3 4 5 6 7 May be to apply the recommendations that may occur in thinking about the potential barriers. 1 2 3 4 5 6 7 Taking into account costs that can occur when to apply the recommendations. 1 2 3 4 5 6 7 Guidelines present the implementation of major criteria that can be monitored and evaluated. 1 2 3 4 5 6 7 Editorial indipendence Independent from the a group sponsored by the contents of the guidelines. 1 2 3 4 5 6 7 Guidelines Development members and record the problems of conflict of interest. 1 2 3 4 5 6 7 Total score A total of 60 guidelines were assessed, and 18 were selected for in-depth analyses using the IOM trustworthy standards; the evaluation items of AGREE II were used for reference (Table 3 ).
Level of Evidence Definition
A Evidence from which the recommendation was derived is clear. One or more randomized controlled trials (RCT), meta-analyses, or systematic review (SR).
B
Evidence from which the recommendation was derived is credible. One or more well-conducted case control studies or non-randomized controlled trials, such as cohort studies.
C Evidence from which the recommendation was derived exists, but is not credible. Low quality evidence such as observational studies and case reports. D Evidence of recommendation is based on clinical experience and expert opinions. Conscious sedation is recommended for dental patients who satisfy the following conditions: ASA of 1 or 2 and no serious behavioral problems, upper airway infections, difficulty in airway maintenance, serious gastro-esophageal reflux, or a history of allergy to the drugs that will be administered.
I D 2. Fasting before sedation
The patient is advised to fast before undergoing sedation according to the following guidelines: clean water -at least 2 hours before sedation; breast milk -at least 4 hours; milk or light meal -at least 6 hours.
IIa A 3. Materials for conscious sedation Preparation of the following materials is recommended for conscious sedation: oxygen supplier -at least 2 oxygen tanks, pressure regulator, oxygen flow meter; oxygen administration device -facial mask, nasal cannula; patient monitoring device -ECG, blood pressure gauge, respiration monitoring device (stethoscope or capnogram), pulse oximetry, thermostat, glucose meter; properly functioning aspirator that can be used at any time; rescue medication -atropine, epinephrine, flumazenil; airway management devices for emergency -oropharyngeal airway, nasopharyngeal airway, Combitube, laryngeal mask, i-gel, bag valve mask; automated external defibrillator; and device for intravenous access if possible.
I D Twelve guidelines were considered for further adaptation (Table 4) . Nonetheless, some of the guidelines that were included, targeted children as their intended audience, and therefore, may reduce the scope of this review. Therefore, the details of the key questions were considered as a novel development.
RESULTS
In a survey of guidelines from developed nations, a total of 60 CPGs were included. From this figure, a total of 12 CPGs were evaluated in a detailed review (Table   4 ). Levels of evidence of literature (or guidelines), used as the scientific evidence from which the recommendations were derived, were classified into four different groups based on their level of evidence by the Clinical Guideline Development Group (Table 5) . Modified GRADE (Grading of Recommendations Assessments, Development, and Evaluation) was used as the standard for grading recommendations. Recommendation grades were classified based on the level of evidence, benefit
Patient monitoring
The patients are monitored by the following parameters during sedation: level of sedation -sedation scales (OAA/S, etc.); respiration -respiratory sound, respiratory exercise, end-tidal CO2 tension; oxygenation -pulse oximetry, skin and mucous membrane color, and time-based regular monitoring -heart rate, blood pressure, capillary refill time.
I A
Conscious sedation records
The following details are recorded every 5 minutes during sedation: sedation scales and vital signs (heart rate, respiratory rate, blood pressure, pulse oximetry).
I D
The following details should be recorded with regards to the drug that is being administered: drug name, dose, route, time, reason, patient's response after the administration; method of supplying oxygen.
I D 6. Discharge criteria
The following details are checked according to discharge criteria (e.g., the Aldrete Score sheet) after confirming that there are no abnormal symptoms associated with dental treatment: recovery to the conscious state prior to sedation; level of oxygen saturation in the atmosphere > 92%; normal movement; ability to take a deep breath and cough; less than 20 mmHg difference in systolic pressure before and after sedation.
I C
A patient is considered for discharge if the following conditions are met after sedation: vital signs within a normal range; patient has controllable pain, nausea, and vomiting; the precautions after sedation has been explained to the patient; the patient is accompanied by a responsible guardian; the patient has not experienced complications associated with dental treatment.
IIa D
Nitrous oxide ventilation facilities
The following facility maintenance is recommended for nitrous oxide sedation: installation of effective ventilation facilities; regular measurement of nitrous oxide concentration; regular ventilation facility inspection. The recommended and maximum doses of chloral hydrate for pediatric dental patients are as follows: oral administration: 25-50 mg/kg, maximum 1 g.
IIb C
If sedative effects of chloral hydrate alone are insufficient, 50% N2O may be used in conjunction with chloral hydrate.
IIb C
Nitrous oxide conscious sedation
The following protocol is recommended for pediatric dental patients: mix nitrous oxide with 3-5 L of oxygen every minute, and monitor the patient's response; slowly increase the amount of nitrous oxide by 10% every 1-2 minutes, up to 50% at maximum; upon the completion of nitrous oxide administration, ventilate with 100% oxygen for 3-5 minutes to prevent diffusion hypoxia I B
and risk, utilization at clinical sites, and other factors (Table 6) . A detailed review of the CPGs revealed 13 main recommendations for general, adult, and pediatric areas ( Table 7) . 
